港股開盤 | 恆指跌破19000點關口,恆生科指大跌5.54%
香港恆生指數3月15日(週二)開盤下跌600.48點,跌幅3.07%,報18931.18點;國企指數3月15日(週二)開盤下跌258.26點,跌幅3.94%,報6297.29點;紅籌指數3月15日(週二)開盤下跌80.25點,跌幅2.16%,報3640.61點。
大型科技股阿裏巴巴、騰訊跌超8%,快手、美團跌超7.5%,京東、網易等均下挫;汽車板塊跌勢不止,理想汽車、比亞迪股份均大跌,全國昨日新增確診3507例,餐飲股、影視娛樂股、航空股、啤酒股、濠賭股皆大跌,半導體股、光伏股、保險股、豬肉概念股、燃氣股、電力股紛紛下挫。另一方面,中藥股逆勢上漲,國藥控股、綠葉製藥高開,海運股、香港銀行股多數上漲。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.